Alvino Mark
SEC Form 4 insider trading activity
Alvino Mark has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Alvino Mark is listed as Director at ABEONA THERAPEUTICS INC. Inside the rolling window, Alvino Mark reported no open-market purchases and 5 open-market sales totaling $275K in ABEO. The largest disclosed transaction in the window is a sale of 15,000 ABEO shares on Sep 1, 2026, worth $88K.
Companies traded
Other insiders at ABEO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$275K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Alvino Mark made?
Alvino Mark has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Alvino Mark trade?
Alvino Mark has filed SEC Form 4 disclosures for 1 company, including ABEO.
When was Alvino Mark's most recent SEC Form 4 filing?
Alvino Mark's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Alvino Mark's total buy and sell value in the current window?
Inside the rolling retention window, Alvino Mark bought $0 and sold $275K based on SEC Form 4 filings.
What was Alvino Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 ABEO shares on 2026-09-01, worth $88K, per SEC Form 4 filings.